American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, ...

Silicosis is an incurable but entirely preventable lung disease. It has only one cause: breathing in too much silica dust.

Lung cancer often goes undetected until it’s too late. But a new urine test developed by Cambridge scientists could change ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Diffusing capacity of the lung for carbon monoxide (DLCO) is a lung function test that may help detect COPD early and predict a person’s outlook. DLCO is a lung diffusion test that measures how ...

CyPath ® Lung’s test result of "Unlikely Lung Cancer" directly prevented a robotic bronchoscopic biopsy or high-risk percutaneous biopsy in response to imaging that showed several new ...

Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...